跳至主要内容
临床试验/KCT0009352
KCT0009352尚未招募Unknown

Multi-center clinical trial for optimal treatment of pediatric very high-risk acute lymphoblastic leukemia in Korea

Seoul National University Hospital0 个研究点目标入组 74 人开始时间: 待定最近更新:
适应症

试验速览

阶段
Unknown
状态
尚未招募
入组人数
74

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
1(Year) 至 19(Year)(—)
性别
All

入选标准

  • Pediatric patients diagnosed with ALL between the ages of 1 and 19 years at the time of diagnosis who meet one or more of the following conditions:
  • - Philadelphia chromosome-positive t(9;22)(q34;q11) or
  • - Patients with failed remission who had blast >5% on bone marrow test after initial remission induction therapy or
  • - Hypodiploidy (Number of chromosomes < 44 (less than 44)) or
  • - E2A-HLF translocation-positive or
  • - When the prognosis is judged to be poor according to NGS-MRD results among high-risk ALL patients
  • (i) In B-ALL, the NGS-MRD after consolidation therapy is 0.01% or more, and the NGS-MRD followed during interim maintenance treatment is also 0.01% or more,
  • (ii) In T-ALL, NGS-MRD is more than 0.01% after consolidation therapy

排除标准

  • -Participants with contraindications to medications
  • -When the study participant or their legal representative withdraws consent
  • -Pregnant or lactating women (patients of child-bearing potential require adequate contraception during the study period)
  • -Participants who are medically unsuitable to participate in this study at the discretion of the investigator
  • Participants participating in other interventional studies other than this protocol

研究者

相似试验

尚未招募
不适用
Multicenter clinical study on the optimal treatment protocol and outcome of cough variant asthma with Chinese and Western Medicinecough variant asthma
ITMCTR2200005741The First Affiliated Hospital of Zhejiang Chinese Medical University
已完成
2 期
Multicenter clinical trials to determine the efficacy and safety of consolidation and maintenance therapy with ixazomib, lenalidomide, dexamethasone (IRd) therapy in patients with multiple myeloma after autologous stem cell transplantation.refractory multiple myeloma
JPRN-UMIN000032674Akita University hosipital24
已完成
2 期
Multicenter clinical trials to determine the efficacy and safety of consolidation and maintenance therapy with ixazomib, lenalidomide, dexamethasone (IRd) therapy in transplant-ineligible multiple myeloma.refractory multiple myeloma
JPRN-UMIN000032675Akita University hosipital41
进行中(未招募)
1 期
A study comparing the effect of chemotherapy with the effect of chemotherapy plus local removal of metastases for patients with cancer of the large bowel which has spread to multiple organs.multi-organ metastatic colorectal cancerMedDRA version: 21.0Level: LLTClassification code 10052362Term: Metastatic colorectal cancerSystem Organ Class: 100000004864
EUCTR2011-005003-32-NLVU University Medical Center, Department of Medical Oncology478
招募中
不适用
A randomized multicenter clinical trial for patients with multi-organ colorectal cancer metastases comparing the combination of chemotherapy and maximal tumor debulking versus chemotherapy alone.
NL-OMON54652Radboud Universitair Medisch Centrum408